Ricky Goldwasser
Stock Analyst at Morgan Stanley
(4.37)
# 363
Out of 4,479 analysts
170
Total ratings
64.08%
Success rate
10.72%
Average return
Main Sectors:
22 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACCD Accolade | Maintains: Equal-Weight | $12 → $6 | $3.53 | +69.97% | 13 | Jun 28, 2024 | |
| DOCS Doximity | Maintains: Underweight | $25 | $26.96 | -7.27% | 6 | Apr 23, 2024 | |
| LFST LifeStance Health Group | Reiterates: Overweight | $10 | $5.06 | +97.63% | 7 | Apr 22, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $618 → $584 | $498.24 | +17.21% | 10 | Apr 5, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $8 → $5.5 | $7.82 | -29.67% | 7 | Nov 10, 2023 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $220 → $205 | $201.48 | +1.75% | 13 | Nov 10, 2023 | |
| OSCR Oscar Health | Maintains: Equal-Weight | $5 → $7.5 | $16.59 | -54.79% | 6 | Aug 30, 2023 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $19 → $12 | $7.88 | +52.28% | 7 | Aug 30, 2023 | |
| CNC Centene | Downgrades: Equal-Weight | $94 → $73 | $66.19 | +10.29% | 9 | Aug 30, 2023 | |
| DGX Quest Diagnostics | Reiterates: Equal-Weight | $145 | $136.64 | +6.12% | 11 | Aug 3, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $285 → $260 | $202.73 | +28.25% | 8 | Aug 3, 2023 | |
| MOH Molina Healthcare | Reiterates: Overweight | $365 | $292.00 | +25.00% | 5 | Jul 14, 2023 | |
| MCK McKesson | Maintains: Overweight | $403 → $420 | $584.83 | -28.18% | 11 | Jan 6, 2023 | |
| AMWL American Well | Maintains: Overweight | $7 → $6 | $0.30 | +1,933.90% | 4 | Jan 6, 2023 | |
| HUM Humana | Maintains: Overweight | $549 → $620 | $374.82 | +65.41% | 10 | Oct 31, 2022 | |
| ELV Elevance Health | Maintains: Equal-Weight | $485 → $500 | $535.92 | -6.70% | 2 | Oct 21, 2022 | |
| CVS CVS Health | Maintains: Overweight | $127 → $124 | $57.52 | +115.58% | 5 | Oct 11, 2022 | |
| CI Cigna | Maintains: Overweight | $296 → $318 | $325.91 | -2.43% | 10 | Aug 17, 2022 | |
| CAH Cardinal Health | Maintains: Overweight | $74 → $70 | $96.54 | -27.49% | 9 | Jul 14, 2022 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $43 → $39 | $11.57 | +237.08% | 12 | Jul 6, 2022 | |
| CTLT Catalent | Maintains: Overweight | n/a | $56.20 | - | 2 | Feb 3, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | n/a | $207.47 | - | 3 | Mar 27, 2020 |
Accolade
Jun 28, 2024
Maintains: Equal-Weight
Price Target: $12 → $6
Current: $3.53
Upside: +69.97%
Doximity
Apr 23, 2024
Maintains: Underweight
Price Target: $25
Current: $26.96
Upside: -7.27%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $5.06
Upside: +97.63%
UnitedHealth Group
Apr 5, 2024
Maintains: Overweight
Price Target: $618 → $584
Current: $498.24
Upside: +17.21%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8 → $5.5
Current: $7.82
Upside: -29.67%
Charles River Laboratories International
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $220 → $205
Current: $201.48
Upside: +1.75%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5 → $7.5
Current: $16.59
Upside: -54.79%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19 → $12
Current: $7.88
Upside: +52.28%
Centene
Aug 30, 2023
Downgrades: Equal-Weight
Price Target: $94 → $73
Current: $66.19
Upside: +10.29%
Quest Diagnostics
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $136.64
Upside: +6.12%
Labcorp Holdings
Aug 3, 2023
Maintains: Overweight
Price Target: $285 → $260
Current: $202.73
Upside: +28.25%
Molina Healthcare
Jul 14, 2023
Reiterates: Overweight
Price Target: $365
Current: $292.00
Upside: +25.00%
McKesson
Jan 6, 2023
Maintains: Overweight
Price Target: $403 → $420
Current: $584.83
Upside: -28.18%
American Well
Jan 6, 2023
Maintains: Overweight
Price Target: $7 → $6
Current: $0.30
Upside: +1,933.90%
Humana
Oct 31, 2022
Maintains: Overweight
Price Target: $549 → $620
Current: $374.82
Upside: +65.41%
Elevance Health
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $485 → $500
Current: $535.92
Upside: -6.70%
CVS Health
Oct 11, 2022
Maintains: Overweight
Price Target: $127 → $124
Current: $57.52
Upside: +115.58%
Cigna
Aug 17, 2022
Maintains: Overweight
Price Target: $296 → $318
Current: $325.91
Upside: -2.43%
Cardinal Health
Jul 14, 2022
Maintains: Overweight
Price Target: $74 → $70
Current: $96.54
Upside: -27.49%
Walgreens Boots Alliance
Jul 6, 2022
Maintains: Underweight
Price Target: $43 → $39
Current: $11.57
Upside: +237.08%
Catalent
Feb 3, 2021
Maintains: Overweight
Price Target: n/a
Current: $56.20
Upside: -
IQVIA Holdings
Mar 27, 2020
Maintains: Overweight
Price Target: n/a
Current: $207.47
Upside: -